Study seeks new treatments for post-traumatic stress disorder in veterans, military personnel (IMAGE)

U.S. Army Medical Materiel Development Activity (USAMMDA)

Study seeks new treatments for post-traumatic stress disorder in veterans, military personnel

Caption

A groundbreaking clinical trial launched October 16, 2023 will explore the promise of new drug treatments for military personnel and veterans suffering from post-traumatic stress disorder (PTSD). The multi-site trial is spearheaded by the U.S. Army Medical Materiel Development Activity (USAMMDA), part of the U.S. Army Medical Research and Development Command, and supported by a project team that includes representatives from the U.S. Air Force, Army, Navy, and Special Operations Command.

Credit

U.S. Army courtesy photo

Usage Restrictions

No restrictions.

License

Public Domain

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.